MYTUS / MITUS Project
Rapid Identification of Mycobacterium tuberculosis & Drug Resistance
Completed R&DActive
Key Facts
Indication
Rapid Identification of Mycobacterium tuberculosis & Drug Resistance
Phase
Completed R&D
Status
Active
Company
About Adaltis
Adaltis is a commercial-stage, privately-held Italian IVD company with a 25+ year history. It has built a diversified portfolio spanning molecular diagnostics instruments and test kits, automated MicroELISA analyzers, and associated reagents. The company leverages both open-platform instruments and proprietary test panels, serving a global market through a direct and partner sales model. Its recent focus includes expanding its syndromic molecular panels and fully integrated 'All-in-One' MDx platforms to capitalize on the growing demand for automated, high-throughput infectious disease testing.
View full company profile